We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Boston Scientific Corporation | NYSE:BSX | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.34 | 0.47% | 72.21 | 72.99 | 71.144 | 71.61 | 6,047,097 | 01:00:00 |
From May 2019 to May 2024
By Dave Sebastian
Boston Scientific Corp. said it swung to a loss for the second quarter, with sales falling 23.87%.
The Marlborough, Mass., maker of medical devices didn't immediately address specific Covid-19 effects in its earnings release Wednesday, though the second quarter has seen fewer doctor visits for elective care due to shelter-in-place measures.
The company posted net loss of $147 million, or 11 cents a share, compared with a profit of $154 million, or 11 cents a share, in the year-ago period.
Adjusted earnings were eight cents a share. Analysts polled by FactSet were expecting adjusted losses of three cents a share.
Sales fell to $2 billion from $2.63 billion in the prior year. Analysts were looking for $1.73 billion. Sales in all regions declined, with the U.S. falling 28.4% and Asia Pacific falling 14.8%. Sales in Europe, Middle East and Africa fell 27.2%, and those in emerging markets fell 19.7%.
Write to Dave Sebastian at dave.sebastian@wsj.com
(END) Dow Jones Newswires
July 29, 2020 07:02 ET (11:02 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Boston Scientific Chart |
1 Month Boston Scientific Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
